Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Multitarget HD-tDCS and Spatial Navigation Memory in Schizophrenia (HD-tDCS-SCZ)

10. November 2026 aktualisiert von: School of Psychology, Northwest Normal University

Effects of Multitarget High-Definition Transcranial Direct Current Stimulation and Learning Strategy on Spatial Navigation Memory in Patients With Schizophrenia: A Randomized Sham-Controlled Study

This study investigated whether multitarget high-definition transcranial direct current stimulation (HD-tDCS), combined with cognitive learning strategies, could improve temporal order memory during spatial navigation in patients with schizophrenia.

Schizophrenia is frequently associated with cognitive impairments, including difficulties remembering the order of events and navigating unfamiliar environments. This study examined whether noninvasive electrical brain stimulation could enhance the benefits of repeated memory testing compared with repeated studying.

In this randomized, single-blind, sham-controlled study, 59 hospitalized patients with schizophrenia were assigned to receive either active or sham HD-tDCS while completing a spatial navigation learning task. Both groups performed forward-testing and restudy conditions. Active stimulation was delivered for 20 minutes, and spatial navigation learning lasted approximately 45 minutes.

Spatial navigation memory was evaluated using landmark-order recall accuracy. Resting-state functional near-infrared spectroscopy (fNIRS) was performed before and after the intervention to examine changes in functional connectivity between prefrontal and parietal brain regions.

The study aimed to determine whether multitarget HD-tDCS could improve spatial navigation memory, enhance the benefits of forward testing, and influence functional connectivity in brain networks involved in cognitive control and spatial attention.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

  1. Background and Rationale:

    Cognitive impairment is a core feature of schizophrenia and contributes to difficulties in daily functioning. Temporal order memory, which refers to the ability to remember the sequence of events, plays an important role in spatial navigation and the organization of everyday experiences. Patients with schizophrenia frequently demonstrate impairments in temporal processing, episodic memory, and spatial navigation.

    The dorsolateral prefrontal cortex (DLPFC) and inferior parietal lobule (IPL) are involved in cognitive control, working memory, spatial attention, and contextual updating. Altered functional interactions between these regions may contribute to cognitive difficulties in schizophrenia.

    High-definition transcranial direct current stimulation (HD-tDCS) is a noninvasive brain stimulation technique that can modulate cortical activity. Multitarget HD-tDCS may influence multiple cortical regions involved in distributed cognitive networks. Combining brain stimulation with cognitive strategies may provide an approach to improving memory performance.

    Forward testing is a learning strategy in which previously studied information is tested before subsequent information is learned. This strategy may facilitate new learning by reducing interference and improving contextual differentiation. The present study investigated whether multitarget HD-tDCS could enhance the effects of forward testing on spatial navigation memory.

  2. Study Design

    This study used a randomized, single-blind, sham-controlled, parallel-group design. Sixty hospitalized patients diagnosed with schizophrenia according to DSM-5 criteria were assigned to either an active HD-tDCS group or a sham stimulation group, with 30 participants allocated to each group.

    Both groups completed the same spatial navigation learning task, including forward-testing and restudy conditions.

  3. Intervention:

    Multitarget HD-tDCS was administered using a Starstim 32 stimulation system (Neuroelectrics, Spain). Stimulation was directed toward dorsolateral prefrontal and parietal cortical regions.

    Participants in the active stimulation group received 2.0 mA stimulation for 20 minutes while performing the spatial navigation learning task. Participants in the sham group underwent the same electrode setup but received only brief current stimulation periods at the beginning and end of the session.

  4. Spatial Navigation Task:

    Participants completed a spatial navigation task involving four routes presented in video format. The task included two learning strategies.

    In the forward-testing condition, participants completed interim memory tests after studying route information. In the restudy condition, participants repeatedly studied route information without equivalent interim testing.

    Route materials and presentation order were counterbalanced across conditions. Spatial navigation performance was assessed using landmark-order recall accuracy during the final route test.

  5. Neuroimaging Assessment:

    Resting-state functional near-infrared spectroscopy (fNIRS) was used to investigate changes in cortical functional connectivity associated with the intervention.

    Eight-minute resting-state fNIRS recordings were obtained before and after the spatial navigation task. The recordings measured changes in oxygenated and deoxygenated hemoglobin concentrations.

    Functional connectivity was estimated between regions associated with the DLPFC and IPL. Changes in functional connectivity were examined to explore potential relationships between brain network activity and spatial navigation performance.

  6. Study Objectives:

The study investigated whether multitarget HD-tDCS combined with cognitive learning strategies could influence immediate temporal order memory during spatial navigation in patients with schizophrenia.

Additional objectives included examining intervention-related changes in resting-state frontoparietal functional connectivity and exploring associations between connectivity measures, cognitive performance, and clinical characteristics.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

60

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Gansu
      • Lanzhou, Gansu, China
        • The Third People's Hospital of Lanzhou

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

17 Jahre bis 62 Jahre (Kind, Erwachsene)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Diagnosis of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Duration of illness of at least 1 year.

Predominantly negative symptoms based on clinical assessment.

Total Positive and Negative Syndrome Scale (PANSS) score greater than 70.

Stable antipsychotic medication for at least 8 weeks.

Montreal Cognitive Assessment (MoCA) score between 10 and 26.

Exclusion Criteria:

  • Substance abuse, excluding caffeine and tobacco use.

Presence of other psychiatric disorders.

Contraindications to transcranial electrical stimulation, including intracranial implants or a history of epilepsy.

Pregnancy or breastfeeding.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Active Multitarget HD-tDCS

Participants received active multitarget high-definition transcranial direct current stimulation (HD-tDCS) at 2.0 mA for 20 minutes while completing spatial navigation learning tasks involving forward-testing and restudy conditions.

Multitarget high-definition transcranial direct current stimulation was administered using a Starstim 32 system (Neuroelectrics, Spain). Active stimulation was delivered at 2.0 mA for 20 minutes, concurrently with spatial navigation learning tasks. Stimulation targeted dorsolateral prefrontal and parietal cortical regions.

Schein-Komparator: Sham HD-tDCS

Participants received sham HD-tDCS using the same electrode montage as the active group, with brief current delivery and approximately 30-second ramping periods at the beginning and end of stimulation, without sustained stimulation. Participants completed the same spatial navigation learning tasks involving forward-testing and restudy conditions.

Sham stimulation was administered using the same Starstim 32 system and electrode montage as the active-stimulation condition. Brief current application, including approximately 30-second ramping periods at the beginning and end of the session, was used without sustained stimulation. Participants performed the same spatial navigation learning tasks as those in the active-stimulation group.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Landmark-Order Recall Accuracy
Zeitfenster: Immediately following the spatial navigation learning task (approximately 45 minutes after task initiation).

Landmark-order recall accuracy was assessed during the final test of the spatial navigation task under forward-testing and restudy learning conditions. Accuracy was calculated as the proportion of correctly recalled landmark-order information, with scores ranging from 0 to 1. Higher scores indicate better temporal order memory performance.

Immediately following the spatial navigation learning task (approximately 45 minutes after task initiation).

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Resting-State DLPFC-IPL Functional Connectivity (HbO)
Zeitfenster: Baseline and immediately after the intervention (8-minute resting-state recordings at each assessment).

Resting-state functional connectivity between dorsolateral prefrontal cortex (DLPFC)-associated and inferior parietal lobule (IPL)-associated regions was assessed using functional near-infrared spectroscopy (fNIRS). Pearson correlation coefficients between predefined regions of interest were Fisher z-transformed and averaged. The outcome was calculated as post-intervention minus pre-intervention connectivity using oxygenated hemoglobin (HbO) signals.

Baseline and immediately after the intervention (8-minute resting-state recordings at each assessment).
Change in Resting-State DLPFC-IPL Functional Connectivity (HbR)
Zeitfenster: Baseline and immediately after the intervention (8-minute resting-state recordings at each assessment).

Resting-state functional connectivity between dorsolateral prefrontal cortex (DLPFC)-associated and inferior parietal lobule (IPL)-associated regions was assessed using functional near-infrared spectroscopy (fNIRS). Pearson correlation coefficients between predefined regions of interest were Fisher z-transformed and averaged. The outcome was calculated as post-intervention minus pre-intervention connectivity using deoxygenated hemoglobin (HbR) signals.

Baseline and immediately after the intervention (8-minute resting-state recordings at each assessment).

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Mitarbeiter

Ermittler

  • Hauptermittler: Wenxi Su, PhD, School of Psychology, Northwest Normal University

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

9. Januar 2026

Primärer Abschluss (Tatsächlich)

20. Mai 2026

Studienabschluss (Tatsächlich)

31. Mai 2026

Studienanmeldedaten

Zuerst eingereicht

10. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

10. November 2026

Zuerst gepostet (Tatsächlich)

16. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

16. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

10. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 20261008
  • 32560207 (Andere Zuschuss-/Finanzierungsnummer: National Natural Science Foundation of China)
  • 2026CXZX-272 (Andere Zuschuss-/Finanzierungsnummer: Gansu Provincial University Graduate Innovation Star Project)
  • GSJKKY2025-19 (Andere Zuschuss-/Finanzierungsnummer: Gansu Provincial Disease Prevention and Control Research Program)
  • GSWSQN2025-25 (Andere Zuschuss-/Finanzierungsnummer: Gansu Provincial Health Research Project)

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Individual participant data will not be shared because the dataset contains sensitive psychiatric and clinical information. The study team has no current plan to make individual-level data available to external researchers.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .